Mangoceuticals Inc [MGRX] stock prices are up 1.09% to $0.88 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MGRX shares have gain 32.94% over the last week, with a monthly amount drifted -20.14%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Mangoceuticals Inc [MGRX] has been fluctuating between $0.52 and $6.15 over the past year. Mangoceuticals Inc [NASDAQ: MGRX] shares were valued at $0.88 at the most recent close of the market.
Analyzing the MGRX fundamentals
The Mangoceuticals Inc [NASDAQ:MGRX] reported sales of 0.47M for trailing twelve months, representing a drop of -36.83%. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -44.37%, Pretax Profit Margin comes in at -45.47%, and Net Profit Margin reading is -45.47%. To continue investigating profitability, this company’s Return on Assets is posted at -1.2, Equity is -1.15 and Total Capital is -1.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8449 points at the first support level, and at 0.8114 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9071, and for the 2nd resistance point, it is at 0.9358.
Ratios To Look Out For
It’s worth pointing out that Mangoceuticals Inc [NASDAQ:MGRX]’s Current Ratio is 0.74. In addition, the Quick Ratio stands at 0.74 and the Cash Ratio stands at 0.6. Considering the valuation of this stock, the price to sales ratio is 28.76, the price to book ratio is 0.78.
Transactions by insiders
Recent insider trading involved JOHNSTON EUGENE M, CFO, that happened on Dec 15 ’25 when 3333.0 shares were sold. CFO, JOHNSTON EUGENE M completed a deal on Dec 09 ’25 to sell 5000.0 shares. Meanwhile, CFO JOHNSTON EUGENE M sold 10000.0 shares on Dec 05 ’25.
